Identification of a site in GluR1 and GluR2 that is important for modulation of deactivation and desensitization

Molecular Pharmacology

Volumn 64, Issue 1, 2003, Pages 5-10

  Leever, J Duncan ^a   Clark, Suzanne ^a   Weeks, Autumn M ^a   Partin, Kathryn M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,4 BENZODIOXAN 6 YLCARBONYL)PIPERIDINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CX 546; CYCLOTHIAZIDE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; ION CHANNEL; IONOTROPIC RECEPTOR; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC CURRENT; HUMAN; HUMAN CELL; NONHUMAN; OOCYTE; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; STEADY STATE; XENOPUS LAEVIS;

AMINO ACID SUBSTITUTION; ANIMALS; BENZOTHIADIAZINES; BINDING SITES; DIOXOLES; GLUTAMIC ACID; KINETICS; MODELS, MOLECULAR; OOCYTES; PIPERIDINES; POINT MUTATION; RECEPTORS, AMPA; SERINE; THREONINE; TRANSFECTION; XENOPUS LAEVIS;

EID: 0038237099     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.1.5     Document Type: Article

References (27)

1. Arai A, Kessler M, Ambros-Ingerson J, Quan A, Yigeter E, Rogers G, and Lynch G (1996a) Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics. Neuroscience 75:573-585.
2. Arai A, Kessler M, Rogers G, and Lynch G (1996b) Effects of a memory-enhancing drug on DL-α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor currents and synaptic transmission in the hippocampus. J Pharmacol Exp Ther 278:627-638.
3. Arai A, Kessler M, Rogers G, and Lynch G (2000) Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol 58:802-813.
4. Arai AC, Xia YF, Kessler M, Phillips D, Granger R, and Lynch G (2002a) Effects of 5′-alkyl-benzothiadiazides on (R,S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor biophysics and synaptic responses. Mol Pharmacol 62:566-577.
5. Arai A, Xia YF, Rogers G, Lynch G, and Kessler M (2002b) Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. J Pharmacol Exp Ther 303:1075-1085.
6. Armstrong N, Sun Y, Chen GQ, and Gouaux E (1999) Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature (Lond) 395:913-917.
7. Creighton TE (1993) Proteins: Structures and Molecular Properties, W.H. Freeman and Co., New York.
8. Dingledine R, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
9. Granger R, Staubli U, Davis M, Perez Y, Nilsson L, Rogers G, and Lynch G (1993) A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task. Synapse 15:326-329.
10. Huang EP and Stevens CF (1998) The matter of mind: molecular control of memory. Essays Biochem 33:165-178.
11. Ingvar M, Ambros-Ingerson J, Davis M, Granger R, Kessler M, Rogers G, Schehr R, and Lynch G (1997) Enhancement by an ampakine of memory encoding in humans. Exp Neurol 146:553-559.
12. Isaac JT, Nicoll RA, and Malenka RC (1999) Silent glutamatergic synapses in the mammalian brain. Can J Physiol Pharmacol 77:735-737.
13. Isaacson JS and Nicoll RA (1991) Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc Natl Acad Sci USA 88:10936-10940.
14. Lynch G (1998) Memory and the brain: unexpected chemistries and a new pharmacology. Neurobiol Learn Mem 70:82-100.
15. Lynch G, Granger R, Ambros-Ingerson J, Davis MC, Kessler M, and Schehr R (1997) Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans. Exp Neurol 145:89-92.
16. Nagarajan N, Quast C, Boxall AR, Shahid M, and Rosenmund C (2001) Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546. Neuropharmacology 31:650-663.
17. Partin KM (2001) Domains regulating AMPA receptor desensitization. J Neurosci 21:1939-1948.
18. Partin KM, Bowie D, and Mayer ML (1995) Structural determinants of allosteric regulation in alternatively spliced AMPA receptors. Neuron 14:833-843.
19. Partin KM, Fleck MF, and Mayer ML (1996) AMPA receptor flip/flop mutants affecting deactivation, desensitization and modulation by cyclothiazide, aniracetam and thiocyanate. J Neurosci 16:6634-6647.
20. Partin KM, Patneau DK, and Mayer ML (1994) Cyclothiazide differentially modulates desensitization of AMPA receptor splice variants. Mol Pharmacol 46:129-138.
21. Pelletier MR and Hablitz JJ (1996) Altered desensitization produces enhancement of EPSPs in neocortical neurons. J Neurophysiol 72:1032-1036.
22. Staubli U, Perez Y, Xu FB, Rogers G, Ingvar M, Stone-Elander S, and Lynch G (1994) Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc Natl Acad Sci USA 91:11158-11162.
23. Sun Y, Olson R, Horning M, Armstrong N, Mayer ML, and Gouaux E (2002) Mechanism of glutamate receptor desensitization. Nature (Lond) 417:245-253.
24. Trussell LO and Otis TS (1996) Physiology of AMPA receptors: biophysical characteristics that subserve integrative roles of synapses, in Excitatory Amino Acids and the Cerebral Cortex (Conti F and Hicks TP eds) pp 63-72, MIT Press, Cambridge, MA.
25. Yamada K (1998) Modulating excitatory synaptic transmission: potential treatment for neurologic disease? Neurobiol Dis 5:67-80.
26. Yamada KA and Rothman SM (1992) Diazoxide reversibly blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurons. J Physiol (Lond) 458:385-407.
27. Zivkovic D, Thompson DM, Bertolino M, DiBella M, Costa E, and Guidotti A (1995) 7-chloro-3-methyl-3-4-dihydro-2H-1,2,4-benzothiadiazine-S,S-dioxide (IDRA21): a benzothiadiazine derivative that enhances cognition by attenuating DL-amino2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization. J Pharmacol Exp Ther 272:300-309.